|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||61.44 - 62.47|
|52 Week Range||54.67 - 67.71|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||N/A|
|Expense Ratio (net)||N/A|
The Franklin Lakes, New Jersey-based company said it had net income of $2.05 per share. Earnings, adjusted for non-recurring costs and restructuring costs, were $2.70 per share. The medical device manufacturer ...
Medical device companies need to focus on value and disease prevention or their products risk becoming commodities, according to a recent report by consulting firm KPMG. Warning! GuruFocus has detected 3 Warning Signs with ZBH.
A divided U.S. appeals court on Wednesday dealt a setback to older job applicants, saying they cannot invoke a federal law against age bias in employment to challenge hiring policies they believe have a discriminatory impact. In an 8-4 decision, the 7th U.S. Circuit Court of Appeals in Chicago said the "plain language" of the Age Discrimination in Employment Act ("ADEA"), which forbids discrimination against people 40 and older, showed that Congress intended that law to cover current employees, not outside job applicants. It also reinstated a federal district judge's dismissal of Illinois resident Dale Kleber's disparate impact claim against CareFusion Corp, a unit of medical device maker Becton Dickinson and Co.
FRANKLIN LAKES, N.J. , Jan. 21, 2019 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 per common share, payable on March ...
said it expects fiscal first-quarter results above Wall Street's expectations. The multinational medical technology company expects quarterly revenue of $4.16 billion for the first fiscal quarter ended Dec. 31, an increase of 35.1% from the prior year, primarily due to the acquisition of C. R. Bard, the company said. Preliminary earnings per share of $2.70 increased 8.9% from $2.48 the prior year, or 14.9% on a currency-neutral basis.
According to GuruFocus' list of 52-week lows, these Guru stocks have reached their 52-week lows. The price of Becton, Dickinson and Co. (BDX) shares has declined to close to the 52-week low of $216.99, which is 21.5% off the 52-week high of $265.87. The company has a market cap of $58.47 billion.
Becton, Dickinson and Co is a healthcare company. The dividend yield of Becton, Dickinson and Co stocks is 1.22%. Becton, Dickinson and Co had annual average EBITDA growth of 4.60% over the past ten years.
Next year's revenue may not be so hot, but earnings should grow nicely as the company captures synergies and pays down debt.
Becton Dickinson (BDX) delivered earnings and revenue surprises of 0.34% and 1.01%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
The Franklin Lakes, New Jersey-based company said it had a loss of 64 cents per share. Earnings, adjusted for non-recurring costs and pretax expenses, were $2.93 per share. The results exceeded Wall Street ...
Becton, Dickinson (BDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.